Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD3 | P35462 | 17/20 | 0.60 |
| ▸ | DRD2 | P14416 | 15/20 | 0.60 |
| ▸ | DRD4 | P21917 | 5/20 | 0.59 |
| ▸ | DRD1 | P21728 | 2/20 | 0.59 |
| ▸ | HTR2A | P28223 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.55 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.55 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3617541 | 0.92 | DRD3 (0.68) | DRD3DRD2DRD4DRD1HTR2A | |
| SCHEMBL3618645 | 0.92 | DRD2 (0.68) | DRD3DRD2DRD4DRD1HTR2A | |
| SCHEMBL3616133 | 0.87 | DRD3 (0.58) | DRD3DRD2DRD4DRD1HTR2A | |
| SCHEMBL14494809 | 0.78 | DRD2 (0.66) | DRD3DRD2DRD4DRD1HTR2A | |
| SCHEMBL4564124 | 0.78 | DRD2 (0.60) | DRD3DRD2DRD4DRD1HTR2A | |
| SCHEMBL4450992 | 0.78 | ALDH1A1 (0.57) | DRD3DRD2DRD4DRD1HTR2A | |
| SCHEMBL3615992 | 0.76 | DRD2 (0.69) | DRD3DRD2DRD4HTR2A | |
| SCHEMBL14494822 | 0.76 | DRD2 (0.62) | DRD3DRD2DRD4HTR2A | |
| SCHEMBL4441972 | 0.75 | DRD2 (0.83) | DRD3DRD2DRD4DRD1HTR2A | |
| SCHEMBL1114388 | 0.75 | LMNA (0.64) | DRD3DRD2DRD4DRD1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2137185-A2 | INDOLIZINES AND AZA-ANALOG DERIVATIVES THEREOF AS CNS ACTIVE COMPOUNDS | Gmeiner, Dr. Peter (DE) | 2009-12-30 | — | — | EP | disclosed |
| WO-2008113559-A2 | INDOLIZINES AND AZA-ANALOG DERIVATIVES THEREOF AS CNS ACTIVE COMPOUNDS | SCHWARZ PHARMA AG (DE) | 2008-09-25 | — | — | WO | disclosed |